Vir Biotechnology (VIR) Other financing activities (2018 - 2026)

Vir Biotechnology has reported Other financing activities for 9 years, with the latest figure at $174000.0 in Q1 2026.

• Quarterly Other financing activities fell 70.9% year-over-year to $174000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 million (up 103.34% YoY) and the FY2025 annual result came in at $2.8 million, up 254.05% from the prior year.
• Other financing activities declined to $174000.0 in Q1 2026 per VIR's latest filing, from $1.4 million in the prior quarter.
• Over five years, Other financing activities peaked at $3.6 million in Q3 2022 and troughed at -$2.9 million in Q4 2023.
• A 5-year average of $471058.8 and a median of $598000.0 in 2025 frame the typical range for Other financing activities.
• The widest YoY moves for Other financing activities: up 377.27% in 2023, down 410.3% in 2023.
• Over 5 years, Other financing activities stood at $932000.0 in 2022, then sank by 410.3% to -$2.9 million in 2023, then soared by 133.47% to $968000.0 in 2024, then jumped by 49.69% to $1.4 million in 2025, then slumped by 87.99% to $174000.0 in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $174000.0, $1.4 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.